Navigation Links
Alfacell Announces Retirement of Chief Executive Officer
Date:4/28/2008

ile enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. In addition to a Phase IIIb study in malignant mesothelioma, Alfacell is conducting a Phase I/II trial of ONCONASE in non-small cell lung cancer (NSCLC) and other solid tumors. For more information, visit http://www.alfacell.com.

Safe Harbor

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, uncertainties involved in the outcome of the company's ongoing Phase IIIb clinical trial for its lead product, the company's ability to secure necessary approvals from regulatory agencies, uncertainties involving the ability of the company to finance research and development activities and its ongoing operations, potential challenges to or violations of patents, dependence upon third-party vendors, and other risks discussed in the company's periodic filings with the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this release.

Media Contact: Investor Contact:

David Schull or Wendy Lau Timothy Engel

Russo Partners Russo Partners

212-845-4271 212-845-4242

David.Schull@russopartnersllc.com Timothy.Engel@russopartnersllc.com


SOURCE Alfacell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Alfacell Reports Financial Results for Second Quarter of Fiscal 2008
2. Alfacell to Host Fiscal Second Quarter 2008 Financial Results Conference Call and Webcast
3. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
4. Alfacell to Host Webinar on RNA Interference-Like Mechanics of RNase Therapeutics on Nov. 29
5. Alfacell to Host Fiscal Fourth Quarter and Year-End 2007 Financial Results Conference Call and Webcast
6. Alfacell to Present at BIO InvestorForum 2007
7. Aida Pharmaceuticals, Inc. Announces Update on Progress of Rh-Apo2L Testing
8. Exelixis Announces May 6 Webcast of Its First Quarter 2008 Financial Results and Business Update Conference Call
9. ATS Medical Announces First Quarter 2008 Earnings Release Date and Conference Call
10. Dialysis Corporation of America Announces First Quarter 2008 Earnings Release Date
11. IDEXX Laboratories Announces First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , September 23, 2014 ... from Imperial Innovations, Cambridge Innovation Capital and Johnson ... clinical cancer genomics company focused on harnessing the ... improve cancer testing and treatment, today announced it ... by Imperial Innovations and including Cambridge Innovation Capital ...
(Date:9/22/2014)... YORK and SANTA CLARA, Calif. ... Corp. (NASDAQ: WBMD ), the leading source ... new WebMD/Medscape survey that provide novel insights ... in aiding diagnosis and care.  Dr. Eric Topol ... and digital medicine, who serves as both Editor-in-Chief of ...
(Date:9/22/2014)... fragments whose job it is to stop bleeding, are ... they can "feel" the physical environment around them, researchers ... respond to surfaces with greater stiffness by increasing their ... platelets and other components of the clotting system, the ... them credit for, in that they are able to ...
(Date:9/22/2014)... University of Minnesota electrical engineering researchers have developed ... time demonstrates mechanical transportation of light. The discovery ... more efficient optical devices for computation and communication. ... electrical and computer engineering assistant professor Mo Li ... published online and will appear in the October ...
Breaking Biology Technology:Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 2Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 3Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 4WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 2WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 3WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 4Platelets modulate clotting behavior by 'feeling' their surroundings 2Engineers show light can play seesaw at the nanoscale 2
... April 20 Shire plc (LSE: SHP,NASDAQ: SHPGY ), the global ... , , Results press release will be issued at: ... Investor conference call time: ... EDT, , Live conference call for investors: , ...
... Mass. April 20 Advanced Instruments, ... Multi-Sample Osmometer as the first true automation-friendly osmometer ... Multi-Sample Osmometer is specifically designed for ... osmolality testing in the biopharmaceutical laboratory," said Kelly ...
... Inc., a development-stage pharmaceutical company discovering and developing ... James D. Thompson, Ph.D., Vice President, Pharmaceutical Development, ... at this year,s American Society for Pharmacology and ... place from April 18-22, 2009 in New Orleans. ...
Cached Biology Technology:Shire plc: First Quarter 2009 Results Date Notification - April 30, 2009 2Advanced Instruments Introduces 2020-BIO Multi-Sample Osmometer as First True Automation-Friendly Osmometer for the Biopharmaceutical Industry 2Advanced Instruments Introduces 2020-BIO Multi-Sample Osmometer as First True Automation-Friendly Osmometer for the Biopharmaceutical Industry 3Quark Pharmaceuticals to Present at American Society for Pharmacology and Experimental Therapeutics Annual Meeting 2Quark Pharmaceuticals to Present at American Society for Pharmacology and Experimental Therapeutics Annual Meeting 3
(Date:9/23/2014)... EdmontonCleaning up oil sands tailings has just gotten a ... University of Alberta civil engineering professors that uses solar ... , Instead of using UV lamps as a light ... retained in tailings ponds, professors Mohamed Gamal El-Din and ... a renewable energy source treats the wastewater just as ...
(Date:9/23/2014)... more carbon than the atmosphere and small changes ... effect on atmospheric greenhouse gas concentrations. A new ... concludes that climate warming does not accelerate ... storage, despite increases in ecosystem productivity. , ... Ecologist Dr. Christian Giardina, with the agency,s Institute ...
(Date:9/23/2014)... West Orange, NJ. September 23, 2014. Kessler Foundation ... of a foot drop stimulator during a task-specific ... system. This finding indicates that applying the foot ... from this common complication of stroke. "EMG of ... utilization of a foot drop stimulator," was published ...
Breaking Biology News(10 mins):Solar energy-driven process could revolutionize oil sands tailings reclamation 2Study helps assess impact of temperature on belowground soil decomposition 2
... Consumers shouldn,t assume that, because a product is ... University of Guelph study reveals some organic pesticides ... pesticides because the organic product may require larger ... PhD candidate Christine Bahlai compared the effectiveness and ...
... that governs flower formation has been uncovered in the daisy-like ... BMC Plant Biology have published a pair of articles ... this process differs from other model plants, such as the ... Teeri, from the University of Helsinki, Finland, worked with a ...
... been puzzled by the ability of microscopic algae to grow ... essential algal nutrient. In this week,s issue of Nature, ... Riser at the University of Washington and David Karl at ... from deep water, as much as 250 meters below the ...
Cached Biology News:Organic pesticides not always 'greener' choice, study finds 2Researchers discover source of essential nutrients for mid-ocean algae 2Researchers discover source of essential nutrients for mid-ocean algae 3
... clone d1-174 GenBank Accession Number : ... N-terminal tagged fusion protein corresponding to full ... Tris-glycine, pH 7.4, 0.15M NaCl, 0.05% sodium ... 30% Quality Assurance: routinely evaluated by immunoblot ...
Rat CXCL7/Thymus Chemokine-1 DuoSet Economy Pack, 45 Plate...
Recombinant Rat Fas Ligand/TNFSF6...
FGF Receptor 1 Antibody...
Biology Products: